BIOREM Reports 2023 Financial Results including $0.14 earnings per share
BIOREM today announced its results for the three and twelve-month periods ended December 31, 2023. Biorem’s complete fiscal 2023 year-end financial statements […]
Author: Sarah Irving
Biorem Reports First Quarter Financial Results
Biorem today announced results for the three month period ended March 31, 2023. Biorem’s complete 2023 first quarter financial statements and MD&A […]
Biorem Reports Record 2022 Financial Results
Biorem today announced its results for the three and twelve-month periods ended December 31, 2022. Biorem’s complete fiscal 2022 year-end financial statements […]
Biorem Reports Third Quarter Results & Increases in Revenues and Earnings
Biorem Reports Third Quarter Results & Increases in Revenues and Earnings BIOREM today announced its results for the three and nine-month periods […]
New growth initiatives drive BIOREM order backlog to record $44.5M
New growth initiatives drive BIOREM order backlog to record $44.5M BIOREM today announced several new orders totalling $7.1 million. The orders are […]
BIOREM Reports Second Quarter Financial Results & Record Order Backlog
BIOREM Reports Second Quarter Financial Results & Record Order Backlog BIOREM today announced its results for the three and six-month periods ended […]
BIOREM order backlog grows to $40 million on strength of $11 million in new orders
BIOREM order backlog grows to $40 million on strength of $11 million in new orders North American sales a “vote of confidence” […]
BIOREM Reports First Quarter Financial Results
Biorem Reports First Quarter Financial Results GUELPH, ON, May 20, 2022 – BIOREM Inc. today announced results for the three month period […]
BIOREM Announces Stock Option Grant
BIOREM Announces Stock Option Grant BIOREM announces that, pursuant to its incentive Stock Option Plan, it has granted incentive stock options to […]